CD8A and infection: Interestingly, administration of CXCL9 in the infection site in mouse brains infected with a recombinant virus in which the UL13 kinase-dead mutation was repaired increased the accumulation of HSV-1-specific CD8+ T cells and inhibited efficient viral propagation and pathogenicity [59].